Stephanie Bordenave-Juchereau

Title: Stephanie Bordenave-Juchereau: Innovator in Alpha-Glucosidase Research

Introduction

Stephanie Bordenave-Juchereau is a notable inventor based in Le Thou, France. She has made significant contributions to the field of medical research, particularly in the area of alpha-glucosidase. Her innovative work has led to the development of a patent that addresses pathological conditions associated with this enzyme.

Latest Patents

Stephanie holds a patent for "Compositions for preventing and/or treating pathological conditions associated with alpha-glucosidase." This composition includes at least one XAP peptide, where X can represent the empty set or a valine. It is designed for use in the prevention and/or treatment of pathologies linked to alpha-glucosidase. Additionally, her patent discusses the use of a hydrolysate of at least one protein, which contains a specific percentage of XAP units, for similar therapeutic purposes.

Career Highlights

Throughout her career, Stephanie has worked with esteemed institutions such as Université de La Rochelle and Université Clermont Auvergne. Her research has focused on developing innovative solutions to complex medical issues, showcasing her dedication to advancing healthcare.

Collaborations

Some of her notable coworkers include Thierry Maugard and Jean-Marie Piot. Their collaborative efforts have contributed to the success of her research and patent development.

Conclusion

Stephanie Bordenave-Juchereau is a pioneering inventor whose work in alpha-glucosidase research has the potential to impact medical treatments significantly. Her contributions to the field exemplify the importance of innovation in addressing health challenges.